Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Baxter
Moodys
Boehringer Ingelheim

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Hydralazine Hydrochloride And Hydrochlorothiazide, and what generic alternatives are available?

Hydralazine Hydrochloride And Hydrochlorothiazide is a drug marketed by Solvay, Superpharm, and Watson Labs. and is included in eight NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.

Summary for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Center for Research Resources (NCRR)Phase 4
Vanderbilt University Medical CenterPhase 4
Vanderbilt University Medical CenterPhase 1/Phase 2

See all HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 087608-001 Feb 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 085446-001 Mar 4, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Superpharm HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 089200-001 Feb 9, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 085440-001 Mar 4, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 087213-001 Feb 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 087609-001 Feb 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 085457-001 Mar 4, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.